LIN CHARLES Y (SR VP, RESEARCH & DEVELOPMENT) sold 4.9% of their position (12.04K shares) of KRONOS BIO, INC. on the open market
Open‑market sale worth $12.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/23/2024ACC: 0001415889-24-005148
Officer· SR VP, RESEARCH & DEVELOPMENT
Since Feb 2024
-12.04K
Net shares
Net seller
$12.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
12.04K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−12.04K
Price / share
$1.05
Trade value
$12.68K
% of position
4.9%
2/21/2024
246.64K→234.60K
Total
Net shares
−12.04K
Net value
-$12.68K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/21/2024 | S · Sale | −12.04K | $1.05 | $12.68K | 4.9% | 246.64K | 234.60K |
| Total | −12.04K | -$12.68K | ||||||
Derivative Transactions0
No derivative transactions reported